173 results match your criteria: "University Hospital of Northern Sweden[Affiliation]"
J Neurol
November 2024
Department of Clinical Neuroscience, University Hospital of Northern Sweden, Umeå University, 90185, Umeå, Sweden.
Acta Oncol
May 2022
Department of Oncology, University Hospital of Northern Sweden, Umeå, Sweden.
Background: Squamous cell cancer of the anus is an uncommon malignancy, usually caused by human papilloma virus (HPV). Chemoradiotherapy (CRT) is the recommended treatment in localized disease with cure rates of 60-80%. Local failures should be considered for salvage surgery.
View Article and Find Full Text PDFNeurooncol Pract
December 2021
Department of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Background: Early extensive surgery is a cornerstone in treatment of diffuse low-grade gliomas (DLGGs), and an additional survival benefit has been demonstrated from early radiochemotherapy in selected "high-risk" patients. Still, there are a number of controversies related to DLGG management. The objective of this multicenter population-based cohort study was to explore potential variations in diagnostic work-up and treatment between treating centers in 2 Scandinavian countries with similar public health care systems.
View Article and Find Full Text PDFActa Neurol Scand
September 2020
Department of Clinical Sciences: Neuroscience, Umeå University, Umeå, Sweden.
Background: During the latest decades, the hypothesis that the subjective experience of free will is determined by preconscious activity in the dominant dorsal medial frontal cortex (dMFC) has repeatedly challenged our commonly held concepts of moral responsibility.
Aims Of The Study: To investigate whether dMFC activity determines the sense of free will and to investigate the effects of resections in this area on quality of life (QoL).
Methods: A cohort of nine patients affected by transient declines in speech and movement skills after surgery involving the left dMFC answered questions about their post-operative, subjective experiences of volition in relation to symptoms.
Eur J Haematol
March 2020
Division of Hematology, Specialist Medicine, NU Hospital Group, Uddevalla, Sweden.
Objective: To explore the relative importance of risk factors, treatments, and blood counts for the occurrence of vascular complications and their impact on life expectancy in essential thrombocythemia (ET) and polycythemia vera (PV).
Methods: Nested case-control study within the Swedish MPN registry. From a cohort of 922 ET patients and 763 PV patients, 71 ET and 81 PV cases with vascular complications were compared with matched controls.
J Rehabil Med Clin Commun
October 2019
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.
Objective: To evaluate comprehensive unmet rehabilitation needs by using a novel graphic screening tool, Rehab-Compass, among individuals in the sub-acute stage after first-ever transient ischaemic attack.
Methods: A pilot prospective cohort study investigated 47 individuals with first-ever transient ischaemic attack in an outpatient clinic setting. By using Rehab-Compass, based on well-validated patient-reported outcome measure questionnaires, this study examined comprehensive unmet rehabilitation needs among individuals at 4-month follow-up after the onset of transient ischaemic attack.
J Neurooncol
November 2019
Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Background: The Mono-amine oxidase-A (MAO-A) enzyme is involved in the degradation and regulation of catecholamines such as serotonin, dopamine, epinephrine and nor-epinephrine. Preclinical studies suggest that this enzyme may contribute to an environment favorable for growth of malignant glioma. The MAO-A gene is located on the X-chromosome and has at least one functional genetic polymorphism.
View Article and Find Full Text PDFNeuropsychologia
June 2019
Umeå Center for Functional Brain Imaging (UFBI), Umeå University, S-901 87, Umeå, Sweden; Department of Integrative Medical Biology, Umeå University, S-901 87, Umeå, Sweden.
The Supplementary Motor Area (SMA)-syndrome is a transient disturbance of the ability to initiate voluntary motor and speech actions that will often occur immediately after neurosurgical resections in the dorsal superior frontal gyrus but will typically have disappeared after 3 months. The purpose of the present study was to investigate the extent to which this syndrome is associated with alterations in cognitive control. Five patients who were to different extents affected by the SMA-syndrome after surgery for WHO grade II gliomas in the left hemisphere, were tested with the color word interference (Stroop) test; the Bergen dichotic listening test and for letter and category verbal fluency before surgery, 1-2 days after surgery and approximately 3 months after surgery.
View Article and Find Full Text PDFFront Neurol
March 2017
Department of Hand Surgery, Skåne University Hospital, Malmö , Sweden.
Recovery after surgical reconstruction of a brachial plexus injury using nerve grafting and nerve transfer procedures is a function of peripheral nerve regeneration and cerebral reorganization. A 15-year-old boy, with traumatic avulsion of nerve roots C5-C7 and a non-rupture of C8-T1, was operated 3 weeks after the injury with nerve transfers: (a) terminal part of the accessory nerve to the suprascapular nerve, (b) the second and third intercostal nerves to the axillary nerve, and (c) the fourth to sixth intercostal nerves to the musculocutaneous nerve. A second operation-free contralateral gracilis muscle transfer directly innervated by the phrenic nerve-was done after 2 years due to insufficient recovery of the biceps muscle function.
View Article and Find Full Text PDFTransfus Apher Sci
February 2017
University Hospital of northern Sweden, Umea University, 90185 Umeå, Sweden. Electronic address:
J Med Eng Technol
July 2016
c Department of Public Health and Clinical Sciences, University Hospital of Northern Sweden and Community Medicine and Rehabilitation, Umeå University, Umeå , Sweden ;
An intelligent rollator (IRO) was developed that aims at obstacle detection and guidance to avoid collisions and accidental falls. The IRO is a retrofit four-wheeled rollator with an embedded computer, two solenoid brakes, rotation sensors on the wheels and IR-distance sensors. The value reported by each distance sensor was compared in the computer to a nominal distance.
View Article and Find Full Text PDFJ Neuroimmunol
March 2016
Department of Pharmacology and Clinical Neuroscience, Umeå University and University Hospital of Northern Sweden, Umeå, Sweden; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
Galectin-9 is produced by activated astrocytes, induces a pro-inflammatory response in microglia and may be important to the pathogenesis of secondary progressive MS. In this study, Galectin-9 concentrations in CSF samples from healthy controls and two independent patient cohorts of MS patients were determined by ELISA. Patients from one of the cohorts underwent MRI as well.
View Article and Find Full Text PDFBMC Pulm Med
December 2015
Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, Umeå, Sweden.
Background: Cardiovascular comorbidity in COPD is common and contributes to increased mortality. A few population-based studies indicate that ischemic electrocardiogram (ECG)-changes are more prevalent in COPD, while others do not. The aim of the present study was to estimate the presence of ischemic heart disease (IHD) in a population-based COPD-cohort in comparison with subjects without COPD.
View Article and Find Full Text PDFToxins (Basel)
November 2015
Department of Hand and Plastic Surgery, University Hospital of Northern Sweden, 90 185 Umea, Sweden.
Botulinum toxin A (BoNT-A) injections for treatment of spasticity in patients with cerebral palsy (CP) have been used for about two decades. The treatment is considered safe but a low frequency of adverse events (AE) has been reported. A good method to report AEs is necessary to verify the safety of the treatment.
View Article and Find Full Text PDFActa Ophthalmol
August 2016
Department of Clinical Neuroscience, Ophtalmology and Vision, Karolinska Institutet, St. Erik Eye Hospital, Stockholm, Sweden.
Front Neurol
March 2015
Department of Pharmacology and Clinical Neuroscience, University Hospital of Northern Sweden, Umeå University, Umeå , Sweden.
Background: Fatigue is a frequent symptom in multiple sclerosis (MS) and often interrelated with depression and sleep disorders making symptomatic treatment decisions difficult. In the single-arm, observational phase IV TYNERGY study, relapsing-remitting MS patients showed a clinically meaningful decrease in fatigue over 1 year of treatment with natalizumab.
Objective: To evaluate whether fatigue improvement might be directly linked to improved depression and day-time sleepiness.
J Neurosurg Pediatr
April 2015
Department of Hand and Plastic Surgery, University Hospital of Northern Sweden, Umeå, Sweden.
Object: The dyskinetic subtype of cerebral palsy is difficult to manage, and there is no established gold standard for treatment. External rotation of the shoulder(s) is often managed nonsurgically using injections of botulinum toxin A into the external rotator muscles. This article reports a new surgical technique for managing external rotation when botulinum toxin A treatment is not sufficient or possible.
View Article and Find Full Text PDFJ Neuroimmunol
December 2014
Department of Immunology, Genetics and Pathology, Science for Life Laboratories, Uppsala University, Uppsala, Sweden.
In this cross-sectional study, we wanted to identify key cytokines characteristic of different stages of multiple sclerosis (MS). To this end, cerebrospinal fluid from patients with MS was investigated with a multiplexed fluorescent bead-based immunoassay. In total 43 cytokines were assessed and related to clinical and imaging data.
View Article and Find Full Text PDFJ Neurol Neurosurg Psychiatry
October 2014
Department of Neuroscience, Uppsala University, Uppsala, Sweden Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.
Background: Autologous haematopoietic stem cell transplantation (HSCT) is a viable option for treatment of aggressive multiple sclerosis (MS). No randomised controlled trial has been performed, and thus, experiences from systematic and sustained follow-up of treated patients constitute important information about safety and efficacy. In this observational study, we describe the characteristics and outcome of the Swedish patients treated with HSCT for MS.
View Article and Find Full Text PDFPLoS One
September 2013
Dept of Pharmacology and Clinical Neuroscience, Umeå University and University Hospital of Northern Sweden, Umeå, Sweden.
Unlabelled: Fatigue is a significant symptom in multiple sclerosis (MS) patients. First-generation disease modifying therapies (DMTs) are at best moderately effective to improve fatigue. Observations from small cohorts have indicated that natalizumab, an antibody targeting VLA-4, may reduce MS-related fatigue.
View Article and Find Full Text PDFMov Disord
July 2010
Department of Neurosurgery, University Hospital of Northern Sweden, Umeå, Sweden.
To evaluate the posterior subthalamic area (PSA) as a target for deep brain stimulation (DBS) in the treatment of essential tremor (ET). The ventral intermediate nucleus of the thalamus is the traditional target for DBS in the treatment of ET. Recent studies have presented beneficial effects of DBS in the PSA in the treatment of tremor.
View Article and Find Full Text PDFFear and anxiety are recurring problems for parents of food-allergic children. However, no study has described parents' experiences of introducing food to their children after double-blind provocation. Therefore the aim of this study was to investigate mothers' experiences during their child's negative Double-Blind, Placebo-Controlled Food Challenge (DBPCFC) and the following reintroduction of food.
View Article and Find Full Text PDFStereotact Funct Neurosurg
October 2010
Department of Neurosurgery, University Hospital of Northern Sweden, Umeå, Sweden. anders.fytagoridis @ neuro.umu.se
Background: The posterior subthalamic area (PSA), including the zona incerta and prelemniscal radiation (Raprl), has recently been presented in number of publications as a promising target for deep brain stimulation (DBS) in the treatment of various movement disorders. In order to evaluate the safety of the procedure, we analyzed our initial 40 patients for complications and side effects.
Methods: 40 patients treated with PSA DBS for Parkinson's disease, essential tremor and other forms of tremor were included.
MAGMA
December 2009
Department of Radiation Sciences, Diagnostic Radiology, Umeå University and University Hospital of Northern Sweden, Umeå, 901 87 Sweden.
Object: Polyunsaturated omega-6 fatty acids (PUFAs) have been shown to promote prostate cancer. Here, we describe the use of HRMAS NMR spectroscopy to detect omega-6 PUFA species in prostate tissues.
Materials And Methods: Samples originating from non-malignant (n = 54) and malignant (n = 27) prostate tissues (from 27 prostatectomized men) were studied by 1D (1)H, 2D (1)H-(1)H and (1)H-(13)C HRMAS NMR spectroscopy followed by histopathological characterization.
Mov Disord
December 2009
Department of Neurosurgery, University Hospital of Northern Sweden, Umeå, Sweden.
To evaluate pallidal DBS in a non-DYT1 form of hereditary dystonia. We present the results of pallidal DBS in a family with non-DYT1 dystonia where DYT5 to 17 was excluded. The dystonia is following an autosomal dominant pattern.
View Article and Find Full Text PDF